4.7 Article

Potent Inhibitors of β-Tryptase and Human Leukocyte Elastase Based on the MCoTI-II Scaffold

Journal

JOURNAL OF MEDICINAL CHEMISTRY
Volume 52, Issue 20, Pages 6197-6200

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/jm901233u

Keywords

-

Funding

  1. European Union
  2. Royal Thai Government
  3. Biotechnology and Biological Sciences Research Council (BBSRC), U.K.
  4. BBSRC [BB/D02014X/1] Funding Source: UKRI
  5. Biotechnology and Biological Sciences Research Council [BB/D02014X/1] Funding Source: researchfish

Ask authors/readers for more resources

MCoTI-lI is a member of a class of microproteins known as cyclotides that possess a macrolactam-cystine knot scaffold imparting exceptional physiological stability and structural rigidity. Modification of residues in the active loop and engineered truncations have resulted in MCoTI-II analogues that possess potent activity against two therapeutically significant serine proteases: beta-tryptase and human leukocyte elastase. These results suggest that MCoTI-II is a versatile scaffold for the development of protease inhibitors against targets in inflammatory disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available